Your browser doesn't support javascript.
loading
Biological Tipping Point in Patients with Atopic Dermatitis Treated with Different Dosing Intervals of Dupilumab.
Dekkers, Coco; der Wal, M Marlot van; El Amrani, Mohsin; Luin, Matthijs van; Bakker, Daphne S; Bruin-Weller, Marjolein de; van Wijk, Femke.
Afiliação
  • Dekkers C; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • der Wal MMV; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • El Amrani M; Department of Clinical Pharmacy, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Luin MV; Department of Clinical Pharmacy, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Bakker DS; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Bruin-Weller M; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van Wijk F; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: f.vanwijk@umcutrecht.nl.
J Invest Dermatol ; 143(9): 1822-1825.e3, 2023 09.
Article em En | MEDLINE | ID: mdl-36997108

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Limite: Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Limite: Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2023 Tipo de documento: Article